
Credo Technology reported a blowout Q2 FY2026 with adjusted EPS of $0.67 (36.7% above the Zacks consensus) and revenue of $268.0M, up 272.1% year-over-year driven by product sales of $261.3M (+278.3%) and IP license revenue of $6.7M (+127.6%). Non-GAAP gross profit was $181.4M with a 67.7% gross margin (up 410 bps), non-GAAP operating expenses of $57.3M, and cash & short-term investments of $813.6M as of Nov. 1, 2025. Management guided Q3 revenue to $335–$345M and raised FY2026 revenue expectations to roughly 170% YoY, citing rapid scale-up at hyperscale AI training/inference customers and upcoming product ramps (ZeroFlap Optics, ALCs, OmniConnect), which sent shares up ~18% premarket.
Market structure: Credo (CRDO) is the clear near-term winner—product revenue +278% YoY and non‑GAAP gross margin ~67.7% signal meaningful pricing/power in high‑speed optics and MACsec for hyperscalers. Hyperscalers and suppliers of AI training infrastructure (optics, gearboxes, ALCs) gain share; legacy low‑margin networking suppliers and small consumer‑facing analog vendors are less exposed and may lose relative spend. Strong guidance (Q3 $335–345M; FY26 ~170% YoY) implies demand > supply near term for 400G/800G components, pressuring lead times and supporting suppliers’ pricing for multiple quarters. Risk assessment: Key tail risk is customer concentration—3–4 customers >10% each means loss/slowdown at one hyperscaler could cut revenue by >10–25% in a quarter; also export controls or FPGAs-to-optics integration by cloud vendors could erode margin. Time horizons: immediate (days) expect continued volatility around prints and design‑win announcements, short term (3–6 months) depends on additional hyperscaler win confirmation, long term (12–24 months) hinges on adoption of ZeroFlap/OmniConnect and competitive entry. Catalysts to watch: new hyperscaler design wins, bookings cadence, and sequential ASPs reported by peers over next 90 days. Trade implications: Tactical long CRDO is justified but size-constrained because of concentration—recommend 2–3% portfolio exposure and add on confirmed new-customer win or Q3 beat; use a 6–9 month call‑spread to cap premium if volatility is elevated. Relative trade: long CRDO vs short NVTS (or other small GaN names) equal notional for 3–9 months—CRDO accelerating while NVTS revenue fell 53% YoY. Rotate toward optical/connectivity suppliers and semiconductor capital equipment; reduce exposure to weak consumer analogs short term. Contrarian angles: The market may be underpricing the concentration and operational execution risk—CRDO’s 138% 6‑month run and 18% intraday move could be overdone if one large customer pauses orders. Historical parallel: early Mellanox network optics saw big repricing until consolidation; similar re‑rating here could reverse quickly on order softness. Hedge with 3–6 month OTM puts or limit position to avoid a 20–30% downside on single large‑customer shock.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.75
Ticker Sentiment